532523:BOM
Biocon Ltd
₹ 350.00
arrow_downward
-0.43%(-1.50) Siku 1
16 Okt, 15:30:00 GMT +5:30 · INR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya 532523...
Fungua
₹ 352.95
Juu
₹ 352.95
Chini
₹ 348.10
Mtaji wa soko
568.79B
Wastani wa kiasi cha mauzo
elfu 692.61
Kiasi cha mauzo ya hisa
elfu 668.34
Gawio
0.14%
Mgawo wa faida wa kila robo mwaka
₹ 0.13
Tarehe ya kutojumuisha gawio
3 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
103.62
Juu kwa wiki 52
₹ 447.00
Chini kwa wiki 52
₹ 337.95
EPS
₹ 3.38
Hisa za wawekezaji
600.00M
Idadi ya wafanyakazi
elfu 16
Fungua
₹ 352.95
Juu
₹ 352.95
Chini
₹ 348.10
Mtaji wa soko
568.79B
Wastani wa kiasi cha mauzo
elfu 692.61
Kiasi cha mauzo ya hisa
elfu 668.34
Gawio
0.14%
Mgawo wa faida wa kila robo mwaka
₹ 0.13
Tarehe ya kutojumuisha gawio
3 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
103.62
Juu kwa wiki 52
₹ 447.00
Chini kwa wiki 52
₹ 337.95
EPS
₹ 3.38
Hisa za wawekezaji
600.00M
Idadi ya wafanyakazi
elfu 16
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
AskTraders.com
·
dakika 33 zilizopita
S&P 500 Can Absorb Fed Hikes, Says UBS CIO After Hot US Inflation
Foreign Policy Journal
·
saa 1 iliyopita
Rigetti Computing (NASDAQ: RGTI) Stock Drops 21% In A Month As Quantum Sector Faces Commercialization Pressure
Traders Union
·
dakika 54 zilizopita
Peter Tuchman: Nasdaq posts worst week since April 2025 tariff selloff as S&P 500 loses $1.3 trillion
Yahoo Finance
·
saa 9 zilizopita
Michael Burry Warns of a Stock Market ‘Supervolcano’
Wasifu
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Kuhusu Biocon Ltd
Afisa Mkuu Mtendaji (CEO)Shreehas P Tambe
Wafanyakazielfu 16.4
Lilianzishwa29 Nov 1978
Makao makuuBangalore, Karnataka, India
Sekta-
Tovutibiocon.com